Skip to content

V60 Ventilator, Model V8000

by Respironics California, Inc.

510(k) K082660

V60 Ventilator, Model V8000 is a medical device (FDA Class II; FDA product code MNT, Continuous, Minimal Ventilatory Support, Facility Use Ventilator) made by Respironics California, Inc., cleared under FDA 510(k) K082660 on 9 Jan 2009, active as of 22 Oct 2026. 44 FDA recalls are linked to it.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

22 ongoing

This device is named in the recall

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK082660 Date9 Jan 2009ClearedStatusActive

Official records

From the FDA record

Received by the FDA
12 Sep 2008
FDA decision
9 Jan 2009 (Substantially Equivalent)
FDA review time
119 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K082660 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Recalls

44 recalls · 22 ongoing · FDA

    • Ongoing Z-1137-2021 FDA Class II initiated 6 Jan 2021

    Due to unqualified "design verification" batteries being shipped to customers.

  • 16 recalls, same reason

    • Ongoing Z-0916-2021 FDA Class II initiated 2 Nov 2020
    • Ongoing Z-0908-2021 FDA Class II initiated 2 Nov 2020
    • Ongoing Z-0911-2021 FDA Class II initiated 2 Nov 2020
    • Ongoing Z-0910-2021 FDA Class II initiated 2 Nov 2020
    • Ongoing Z-0906-2021 FDA Class II initiated 2 Nov 2020
    • Ongoing Z-0907-2021 FDA Class II initiated 2 Nov 2020
    • Ongoing Z-0917-2021 FDA Class II initiated 2 Nov 2020
    • Ongoing Z-0909-2021 FDA Class II initiated 2 Nov 2020
    • Ongoing Z-0903-2021 FDA Class II initiated 2 Nov 2020
    • Ongoing Z-0904-2021 FDA Class II initiated 2 Nov 2020
    • Ongoing Z-0912-2021 FDA Class II initiated 2 Nov 2020
    • Ongoing Z-0914-2021 FDA Class II initiated 2 Nov 2020
    • Ongoing Z-0915-2021 FDA Class II initiated 2 Nov 2020
    • Ongoing Z-0905-2021 FDA Class II initiated 2 Nov 2020
    • Ongoing Z-0913-2021 FDA Class II initiated 2 Nov 2020
    • Ongoing Z-0902-2021 FDA Class II initiated 2 Nov 2020

    Potential issues with ventilator navigation ring interface and liquid ingress: 1) The navigation ring may become inoperative or operate intermittently; 2) The navigation ring may cause ventilator parameter values to change erratically during setting entries and adjustments.

    • Ongoing Z-1622-2020 FDA Class II initiated 5 Mar 2020

    Solder connection failure on Power Management printed circuit board assembly of ventilators may cause 1) Blower to lose power, spool down, and trigger visual and audible High Priority Check Vent alarm indicating a need for alternative ventilation, or 2) Intermittent connection may disrupt expected operation and trigger unexpected shutdown without alarm. Failures may lead to hypercarbia/hypoxemia

  • 3 recalls, same reason

    • Ongoing Z-1155-2020 FDA Class II initiated 11 Sep 2019
    • Ongoing Z-1153-2020 FDA Class II initiated 11 Sep 2019
    • Ongoing Z-1154-2020 FDA Class II initiated 11 Sep 2019

    Ventilator touchscreen may become frozen and fail to respond to touch commands. If a patient requires a change in therapy, there is no warning associated with an unresponsive touchcreen, and therefore the clinician would have no prior indication of a touchscreen failure and would be unable to change ventilator settings. The ventilator will continue to function at the predetermined and accepted settings required to support the patient. A delay in therapy adjustments may result in hypercarbia and/or hypoxemia.

    • Ongoing Z-1152-2020 FDA Class II initiated 11 Sep 2019

    Ventilator touchscreen may become frozen and fail to respond to touch commands. If a patient requires a change in therapy, there is no warning associated with an unresponsive touchscreen, and therefore the clinician would have no prior indication of a touchscreen failure and would be unable to change ventilator settings. The ventilator will continue to function at the predetermined and accepted settings required to support the patient. A delay in therapy adjustments may result in hypercarbia and/or hypoxemia.

  • 17 recalls, same reason

    • Terminated Z-0885-2021 FDA Class II initiated 30 Oct 2020
    • Terminated Z-0899-2021 FDA Class II initiated 30 Oct 2020
    • Terminated Z-0889-2021 FDA Class II initiated 30 Oct 2020
    • Terminated Z-0901-2021 FDA Class II initiated 30 Oct 2020
    • Terminated Z-0898-2021 FDA Class II initiated 30 Oct 2020
    • Terminated Z-0888-2021 FDA Class II initiated 30 Oct 2020
    • Terminated Z-0895-2021 FDA Class II initiated 30 Oct 2020
    • Terminated Z-0886-2021 FDA Class II initiated 30 Oct 2020
    • Terminated Z-0900-2021 FDA Class II initiated 30 Oct 2020
    • Terminated Z-0890-2021 FDA Class II initiated 30 Oct 2020
    • Terminated Z-0891-2021 FDA Class II initiated 30 Oct 2020
    • Terminated Z-0887-2021 FDA Class II initiated 30 Oct 2020
    • Terminated Z-0894-2021 FDA Class II initiated 30 Oct 2020
    • Terminated Z-0892-2021 FDA Class II initiated 30 Oct 2020
    • Terminated Z-0897-2021 FDA Class II initiated 30 Oct 2020
    • Terminated Z-0893-2021 FDA Class II initiated 30 Oct 2020
    • Terminated Z-0896-2021 FDA Class II initiated 30 Oct 2020

    Ventilator may experience potential issues with the backup battery failures: 1) if the battery is allowed to over discharge, or 2) if the ventilator is stored for an extended period of time without being plugged into AC power.

    • Terminated Z-2061-2017 FDA Class I initiated 24 Apr 2017

    Over time, low-frequency vibrations can cause the pins within the female connectors on the Motor Controller to Data Acquisition Board ribbon cable to become partially displaced causing momentary high resistance that prevents or restricts data travelling through the cable during the high resistance event.

    • Terminated Z-1537-2013 FDA Class I initiated 4 Jun 2013

    Respironics California, Inc. has initiated a recall on the V60 ventilator because of an issue with the software on the V60 Power Management Board Assembly. If a component fails on the Power Management Board Assembly, it may cause ventilator support to be lost with potentially no audible alarm from the ventilator.

    • Terminated Z-2260-2012 FDA Class I initiated 31 Jul 2012

    Respironics is recalling the V60 ventilator because certain blower motor assemblies in the V60 ventilators may not meet specifications. Specifically, the impeller may not be properly seated on the blower motor shaft. This could subsequently cause the blower to cease functioning which would result in the failure of the V60 ventilator to deliver therapy to the patient due to the loss of ventilatio

    • Terminated Z-0457-2011 FDA Unclassified (pre-2012) initiated 2 Jul 2010

    Respironics California Inc has received customer complaints of an odor or burning smell coming from the V60 Ventilator, and identified a component on the Power Management PCB that exhibited thermal damage.

    • Terminated Z-0176-2010 FDA Unclassified (pre-2012) initiated 26 Oct 2009

    The recall was initiated to correct an issue with a component on the V60 Ventilator Power Management (PM) Printed Circuit Board (PCB). A component on the PCB has the potential to break off or become damaged if the PCB is removed from the ventilator. If this occurs, the ventilator may not properly switch between back up battery power and AC power. This can result in power loss during ventilation fo

Timeline

45 dated events

  1. Recall initiated FDA recalls Z-0909-2021
  2. Recall initiated FDA recalls Z-0903-2021
  3. Recall initiated FDA recalls Z-0904-2021
  4. Recall initiated FDA recalls Z-0912-2021
  5. Recall initiated FDA recalls Z-0914-2021
  6. Recall initiated FDA recalls Z-0915-2021
  7. Recall initiated FDA recalls Z-0905-2021
  8. Recall initiated FDA recalls Z-0913-2021
  9. Recall initiated FDA recalls Z-0902-2021
  10. Recall initiated FDA recalls Z-1137-2021

35 earlier events are in the sections above.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
MNT
Device class
Class II
Regulation
21 CFR Part 868.5895
Advisory committee
Anesthesiology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code MNT (Continuous, Minimal Ventilatory Support, Facility Use Ventilator).

Other devices from Respironics California, Inc.

See all devices from Respironics California, Inc. →